Current medical management of chronic stable angina (Q28213164)

Journal of Cardiovascular Pharmacology and Therapeutics

Europe PubMed Central

title

Current medical management of chronic stable angina (English)

0 references

1 reference

Udho Thadani

1

0 references

language of work or name

English

0 references

publication date

September 2004

0 references

published in

0 references

volume

9 Suppl 1

0 references

page(s)

S11-29; quiz S98-9

0 references

cites work

Characteristics of a contemporary population with angina pectoris. TIDES Investigators.

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Choosing the most appropriate treatment for stable angina. Safety considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Exercise capacity and mortality among men referred for exercise testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Management of patients with chronic stable angina at low risk for serious cardiac events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Twenty-two-year follow-up in the VA Cooperative Study of Coronary Artery Bypass Surgery for Stable Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Two- to three-year follow-up of patients with single-vessel coronary artery disease randomized to PTCA or medical therapy (results of a VA cooperative study). Veterans Affairs Cooperative Studies Program ACME Investigators. Angioplasty Compared to M

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Short and long-acting oral nitrates for stable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Ointments and transdermal nitroglycerin patches for stable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Comparison of adrenergic beta-receptor antagonists in angina pectoris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Calcium channel antagonists in the treatment of coronary artery disease: fundamental pharmacological properties relevant to clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Selective L-type, T-type, and nonspecific calcium-channel blockers for stable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Verapamil use in patients with cardiovascular disease: an overview of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Comparative efficacy and safety of bepridil and diltiazem in chronic stable angina pectoris refractory to diltiazem. The Bepridil Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Combination propranolol and bepridil therapy in stable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Value of the addition of amlodipine to atenolol in patients with angina pectoris despite adequate beta blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Combined use of calcium-channel and beta-adrenergic blockers for the treatment of chronic stable angina. Rationale, efficacy, and adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Attenuation of anti-ischemic efficacy during chronic therapy with nicorandil in patients with stable angina pectoris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Glucose and glycogen utilisation in myocardial ischemia--changes in metabolism and consequences for the myocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Oleate plus Oxfenicine Improves Functional Recovery, Assessed via an Intraventricular Balloon, in Ischemic-Reperfused Rat Hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Effects of ranolazine on the exercise capacity of rats with chronic heart failure induced by myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Dilate or defer? View of a skeptic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Bringing reality to drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Aspirin as a therapeutic agent in cardiovascular disease. Special Writing Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

The evolving role of statins in the management of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Alcohol inflammation and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Refractory angina pectoris: mechanism and therapeutic options.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Improved exercise tolerance following enhanced external counterpulsation: cardiac or peripheral effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina; evaluation by(13)N-ammonia positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

The International EECP Patient Registry (IEPR): design, methods, baseline characteristics, and acute results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Transcutaneous electrical nerve stimulation (TENS) in angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Influence of naloxone on the effects of high frequency transcutaneous electrical nerve stimulation in angina pectoris induced by atrial pacing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Transcutaneous electrical nerve stimulation (TENS) for treatment of severe angina pectoris refractory to maximal medical and surgical management--a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Dorsal column stimulation for pain relief from intractable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Epidural spinal electrical stimulation for severe angina: a study of its effects on symptoms, exercise tolerance and degree of ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Spinal cord stimulation for chronic intractable angina pectoris: a unified theory on its mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Neurostimulation treatment for angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Transmyocardial laser revascularization: results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Ultrastructural and immunohistochemical analysis of early myocardial changes following transmyocardial laser revascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

The transmyocardial laser revascularization international registry report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. ATLANTIC Investigators. Angina Treatments-Lasers and Normal Therapies in Comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Perioperative morbidity and mortality after transmyocardial laser revascularization: incidence and risk factors for adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

A prospective, multicenter, randomized trial of percutaneous transmyocardial laser revascularization in patients with nonrecanalizable chronic total occlusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Vascular endothelial growth factor enhances atherosclerotic plaque progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Association between cardiac valvular calcification and coronary artery disease in a low-risk population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103

Meta-analysis of Trials Comparing β-Blockers, Calcium Antagonists, and Nitrates for Stable Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900103